Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04996901
  4. Details
NCT04996901 Clinical Trial

The Chinese STEMI PPCI Registry (CSPR)

ST-segment Elevation Myocardial Infarction (STEMI) Clinical Trial

Official title:
The Chinese ST-Segment Elevation Myocardial Infarction Primary Percutaneous Coronary Intervention Registry

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04996901
Other study ID # 958374
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 22, 2021
Est. completion date December 5, 2021

Study information
Verified date December 2021
Source Renmin Hospital of Wuhan University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.

Description:

The CSPR trial is an observational clinical trial to derive and validate a readily useable risk score to identify patients at high risk of in-hospital major adverse cardiac events in 5594 patients presenting with a ST-segment elevation myocardial infarction and treated by primary percutaneous coronary intervention.

Recruitment information / eligibility
Status Completed
Enrollment 5594
Est. completion date December 5, 2021
Est. primary completion date December 5, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Age=18 2. ST-segment elevation myocardial infarction was defined according to the universal definition of myocardial infarction 3. STEMI treated by pPCI Exclusion Criteria: 1. Patient with heart failure in admission 2. STEMI with symptom-onset-to-balloon time>24h 3. pPCI was not successful or only underwent coronary angiography 4. Killip class =II in admission

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• no intervention
no intervention

Locations
Country Name City State
China Renmin Hospital of Wuhan university Wuhan Hubei

Sponsors (7)
Lead Sponsor Collaborator
Renmin Hospital of Wuhan University Jiangxi Provincial People's Hopital, The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, The First Affiliated Hospital of Dalian Medical University, The First College of Clinical Medical Science, China Three Gorges University, Wuhan Third Hospital, Xiangyang No.1 People's Hospital

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary in-hospital acute de novo heart failure Killip class =II in-hospital outcome, until discharge
Primary cardiogenic shock according to the universal definition in-hospital outcome, until discharge
Primary death according to the universal definition in-hospital outcome, until discharge
See also
  Status Clinical Trial Phase
Recruiting NCT04962178 - Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset N/A
Not yet recruiting NCT04549766 - Predictive Value of PRECISE DAPT Score in STEMI Patients After Primary PCI
Not yet recruiting NCT05511831 - The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI Phase 4
Completed NCT05649696 - Prolonged Clinical Follow-up of OPTIMA-5 Phase 4
Recruiting NCT05506449 - The RECOVER IV Trial N/A
Completed NCT01144819 - Platelet Inhibition in the Acute Phase of STEMI N/A
Recruiting NCT03539133 - Systemic Organ Communication in STEMI
Completed NCT01642667 - Pharmacoinvasive Therapy With Prourokinase Phase 2/Phase 3
Completed NCT04131816 - HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program N/A
Recruiting NCT03768453 - EARLY-MYO-CMR Registry
Completed NCT04942977 - Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy N/A
Recruiting NCT04912518 - Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction N/A
Recruiting NCT05892042 - Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction N/A
Completed NCT02197117 - Effect of Remote Ischemic Conditioning in Heart Attack Patients N/A
Completed NCT02733341 - The Effect of IV Cangrelor and Oral Ticagrelor Study Phase 4
Not yet recruiting NCT04110691 - Impact of Stent Length and Diameter on Patients Undergoing Primary PCI
Recruiting NCT05510661 - Use of Export in Primary Percutaneous Coronary Intervention N/A
Recruiting NCT05709626 - PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction Phase 4
Recruiting NCT05046483 - Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI
Active, not recruiting NCT04828681 - Angio-IMR and Cardiac MR-derived MVO in STEMI Patients